Cutler Group’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Cutler Group’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-30,300	Closed	-$20K	–	7864
2016 Q4	$20K	Sell	30,300 -8,000	-21%	-$96.3K	﹤0.01%	3498
2016 Q3	$9K	Buy	38,300 +26,500	+225%	+$266K	﹤0.01%	4398
2016 Q2	$10K	Buy	+11,800	New	+$88.5K	﹤0.01%	4224
2016 Q1	–	Sell	-5,200	Closed	-$12K	–	7715
2015 Q4	$12K	Buy	+5,200	New	+$34.1K	﹤0.01%	3998

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Cutler Group's ARIA Position: Q1 2017 in Review

Cutler Group sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 12,844 shares — an estimated $159K sold.

Cutler Group first reported a position in ARIA in Q2 2016 and held it in 3 quarters. The position peaked at $159K in Q4 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Cutler Group reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Cutler Group sold 12,844 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $159K.
Cutler Group first reported a position in Ariad Pharmaceuticals Inc in Q2 2016 and held it in 3 quarters.
Cutler Group's Ariad Pharmaceuticals Inc position peaked at $159K in Q4 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Cutler Group's 13F filing for Q1 2017, filed 11 Apr 2017.